Safety and Efficacy of Neoadjuvant Immunochemotherapy in Elderly Patients With Resectable Esophageal Cancer
Clinical trial NCT06403878 · RECRUITING
Trial details
- NCT number
- NCT06403878
- Sponsor
- Sichuan University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-01
- Primary completion
- 2026-05-01
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.